The majority of kEDS patients harbor biallelic mutations in the PLOD1 gene, encoding lysyl hydroxylase 1 (LH1), which catalyzes hydroxylation of specific helical lysine residues within the pro-α collagen chains (Brady et al., 2017). Here, PLOD1 is linked to Ehlers-Danlos syndrome, kyphoscoliotic type 1.